(+)-3′-angeloyloxy-4′-keto-3′,4′-dihydroseselin for treating inflammation
US9408828B2 · kind B2 · utility
0Cited by
0References
6Claims
0Family size
Inventors
Key dates
| Filing date | Jun 18, 2015 |
| Grant date | Aug 9, 2016 |
| Priority date | — |
| Expiry date | Jun 18, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/37
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides a compound, namely (+)-3′-Angeloyloxy-4′-keto-3′,4′-dihydroseselin (Pd-Ib) derived from Bupleurum malconense as the potential anti-inflammation drug. The present invention also relates to methods of preparing the compounds and using the same for treating inflammation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.